P1.12B.10 Dose Adjustments and Exposure-Response Associated with Selpercatinib in Patients with Advanced NSCLC

• DOI: 10.1016/j.jtho.2024.09.369
• Publication Date: 2024-10-16T02:44:03Z
• Authors: K. Park; E. Arriola; M. Pérol; C. Zhou; K. Goto; H. Loong; S.S. Barker; A.C. Massey; P.M. Peterson; D. Liu; A. Akil; B. Solomon